Clinical update 2007: Making strides in the management of chronic myeloid leukemia

American Journal of Health-System Pharmacy

Volumn 64, Issue 24 SUPPL., 2007, Pages

  Frame, David ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BUSULFAN; DASATINIB; HYDROXYUREA; IMATINIB;

CANCER CHEMOTHERAPY; CHROMOSOME ANALYSIS; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONFERENCE PAPER; DRUG MECHANISM; FLU LIKE SYNDROME; GENE TRANSLOCATION; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; STEM CELL TRANSPLANTATION;

EID: 37249047962     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070485     Document Type: Conference Paper

References (8)

1. Preston DL, Kusumi S, Tomonaga M et al. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Radiat Res. 1994; 137:S68-S97.
2. Herr R, Ferguson J, Myers N et al. Cigarette smoking, blast crisis, and survival in chronic myeloid leukemia. Am J Hematol. 1990; 34:1-4.
3. Morgan GJ, Alvares CL. Benzene and the hemopoietic stem cell. Chem Biol Interact. 2005; 153-154:217-22.
4. Sawyers CL. Chronic myeloid leukemia. N Engl J Med. 1999; 340:1330-40.
5. Nowell PC, Hungerford DA. A minute chromosome in human chronic granulocytic leukemia. Science. 1960; 132:1497.
6. Pane F, Intrieri M, Quintarelli C et al. BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations. Oncogene. 2002; 21:8652-67.
7. Kantarjian H, Sawyers C, Hochhaus A et al. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med. 2002; 346:645-52.
8. O'Brien SG, Guilhot F, Larson RA et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med. 2003; 348:994-1004.